Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,415 | 2,124 | 3,806 | 7,229 | 2,869 |
| Other current assets | 305 | 346 | 0 | 0 | 0 |
| TOTAL | $15,265 | $3,209 | $4,514 | $8,102 | $3,456 |
| Non-Current Assets | |||||
| PPE Net | 6 | 7 | 10 | 11 | 12 |
| Other Non-Current Assets | 1 | 189 | 216 | 243 | 270 |
| TOTAL | $7 | $196 | $225 | $254 | $282 |
| Total Assets | $15,272 | $3,405 | $4,739 | $8,356 | $3,738 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 172 | 448 | 265 | 919 | 1,287 |
| Accrued Expenses | 308 | 775 | 424 | 435 | 461 |
| TOTAL | $984 | $1,848 | $690 | $1,446 | $1,976 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 64 | 95 | 126 | 155 |
| TOTAL | $N/A | $64 | $95 | $126 | $155 |
| Total Liabilities | $989 | $1,912 | $785 | $1,572 | $2,131 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 272 | 280 | 28 | 16 | 16 |
| Common Shares | 2 | 0 | 3 | 3 | 3 |
| Retained earnings | -290,949 | -289,542 | -286,993 | -284,077 | -281,216 |
| TOTAL | $14,278 | $1,493 | $3,954 | $6,784 | $1,606 |
| Total Liabilities And Equity | $15,267 | $3,405 | $4,739 | $8,356 | $3,738 |